TIPE2 deficiency accelerates neointima formation by downregulating smooth muscle cell differentiation

30Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Phenotypic switching of vascular smooth muscle cells (VSMCs) is known to play a key role in the development of atherosclerosis. However, the mechanisms that mediate VSMC phenotypic switching are unclear. We report here that TIPE 2, the tumor necrosis factor (TNF) α-induced protein 8-like 2 (TNFAIP8L2), plays an atheroprotective role by regulating phenotypic switching of VSMCs in response to oxidized low-density lipoprotein (ox-LDL) stimuli. TIPE 2-deficient VSMCs treated with ox-LDL expressed lower levels of contractile proteins such as SMaA, SM-MHC and calponin, whereas the proliferation, migration and the synthetic capacity for growth factors and cytokines were increased remarkably. Furthermore, TIPE 2 inhibited VSMCs proliferation by preventing G1/S phase transition. Interestingly, these effects of TIPE 2 on VSMCs were dependent on P38 and ERK1/2 kinase signals. As a result, neointima formation was accelerated in the carotid arteries of TIPE 2-deficient mice. These results indicate that TIPE 2 is a potential inhibitor of atherosclerosis. © 2013 Landes Bioscience.

Cite

CITATION STYLE

APA

Zhang, G., Zhang, W., Lou, Y., Xi, W., Cui, J., Geng, M., … Liu, S. (2013). TIPE2 deficiency accelerates neointima formation by downregulating smooth muscle cell differentiation. Cell Cycle, 12(3), 501–510. https://doi.org/10.4161/cc.23325

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free